Antifertility recombinant plasmid and genetic vaccine and preparation method and applications thereof
A technology of recombinant plasmids and gene vaccines, applied in biochemical equipment and methods, botany equipment and methods, gene therapy, etc., can solve the problems of mouse embryo death, embryonic dysplasia, etc., and achieve the reduction of mouse fertility and strong immune effect , the effect of stable operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Example 1 : Cloning the full-length cDNA of rat uterus Cyp26a1
[0026] This embodiment is the full-length cDNA clone of rat uterus Cyp26a1, and the specific steps are as follows:
[0027] (1) Animal tissue collection: Select sexually mature Spreqne-Dawley female rats weighing 220-260 g, and mated with male rats (1:1) in the estrus period, and take pregnant D3-D6 uteri, and remove the mesentery tissues and embryos.
[0028] (2) Extraction and purification of total RNA from the pregnant uterus: using RNAgents from Promega The Total RNA Isolation System kit was used to extract the total RNA of the pregnant uterus, and the TRIzol was used to extract the total RNA of the tissue in one step. Cut the tissue with bacterial scissors, transfer the homogenate to an Eppendorf tube, add 0.2ml chloroform, shake for 15 sec, let stand at room temperature for 2-3min, centrifuge at 12,000rpm for 15min (4°C), take the supernatant to a new Eppendorf tube, Add 0.5ml of isopropanol, mi...
Embodiment 2
[0036] Example 2 : Construction of recombinant plasmids containing Cyp26a1
[0037] This example is the construction of the recombinant plasmid containing Cyp26a1 of the present invention, which is to recombine the full-length cDNA fragment of Cyp26a1 into PCR 3.1 In the eukaryotic expression plasmid (Invitrogen product, purchased from Beijing Zhongyuan Leading Technology Co., Ltd.), see the specific plasmid map figure 2 , the recombinant plasmid constructed is the anti-fertility PCR3.1-Cyp26a1 gene vaccine, and the specific operations are as follows:
[0038] The PCR product Cyp26a1 cDNA fragment amplified after purification and recovery in Example 1 was connected into the pMD18-T vector (Takara product, purchased from Beijing Liuhetong Economic and Trade Co., Ltd.) and transformed into DH5α competent cells (purchased from Beijing Quanshijin Biotechnology Co., Ltd. Ltd.). Pick the positive clone and shake the bacteria, and after the sequencing and identification are cor...
Embodiment 3
[0039] Example 3 : In vitro expression identification of pCR3.1-Cyp26a1 gene vaccine
[0040] This example is for the pCR3.1-Cyp26a1 gene vaccine constructed in Example 2, to carry out the identification of the in vitro transient expression and expression content of the exogenous Cyp26a1 gene, which is divided into two parts: the in vitro mRNA expression of the Cyp26a1 gene and the in vitro protein expression of the exogenous Cyp26a1 .
[0041] (1) In vitro mRNA expression of Cyp26a1 gene:
[0042] The in vitro transient expression system of human cervical cancer (HeLa) cells and Chinese hamster ovary (CHO) cells (purchased from the Cell Center of the Basic Institute of Peking Union Medical College) was established. The specific operations are as follows: PCR3.1-Cyp26a1 eukaryotic expression plasmid was injected into After transfection, the culture medium was collected at 24 hours, 48 hours, and 72 hours, and the total RNA of the collected transfected HeLa cells and CHO c...
PUM

Abstract
Description
Claims
Application Information

- Generate Ideas
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com